Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-080597
Filing Date
2024-03-28
Accepted
2024-03-28 16:06:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6199
2 GRAPHIC g791869dsp01.jpg GRAPHIC 4575
  Complete submission text file 0001193125-24-080597.txt   13720
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)